Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
University of Colorado Denver
Aurora, Colorado
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 36
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| David Raben | Conflict of Interest | Astra Zeneca | $150,000 - $199,999 | 2017 |
| Manisah Patel | Conflict of Interest | Aeolus Pharmaceuticals, Inc. | $100,000 - $149,999 | 2017 |
| Gary S. Kahn | Conflict of Interest | Healthbridge Systems, LLC | $40,000 - $59,999 | 2017 |
| Manisah Patel | Conflict of Interest | Aeolus Pharmaceuticals, Inc. | $40,000 - $59,999 | 2017 |
| Saptarsi Haldar | Conflict of Interest | Gladstone Institutes | $40,000 - $59,999 | 2017 |
| Anthony Elias | Conflict of Interest | AstraZeneca | $40,000 - $59,999 | 2018 |
| Myron Levin | Conflict of Interest | GlaxoSmithKline | $20,000 - $39,999 | 2019 |
| Adriana Weinberg | Conflict of Interest | GlaxoSmithKline | $20,000 - $39,999 | 2019 |
| Myron Levin | Conflict of Interest | GlaxoSmithKline | $10,000 - $19,999 | 2019 |
| Adriana Weinberg | Conflict of Interest | GlaxoSmithKline | $10,000 - $19,999 | 2019 |
| James Moore | Conflict of Interest | Bristol Myers Squibb Pharmaceutical | $5,000 - $9,999 | 2017 |
| James Moore | Conflict of Interest | Bristol Myers Squibb Pharmaceutical | $5,000 - $9,999 | 2017 |
| Steven Schuster | Conflict of Interest | Janssen Pharmaceutical Inc | $5,000 - $9,999 | 2018 |
| Robert Doebele | Conflict of Interest | Pfizer | $5,000 - $9,999 | 2016 |
| Robert C. Doebele | Conflict of Interest | Pfizer Incorporated | $5,000 - $9,999 | 2015 |
| Sana Karam | Conflict of Interest | AstraZeneca | $5,000 - $9,999 | 2018 |
| Manisah Patel | Conflict of Interest | Aeolus Pharmaceuticals, Inc. | $0 - $4,999 | 2017 |
| James Degregori | Conflict of Interest | Mitotherapeutix | 2019 | |
| Aaron Michels | Conflict of Interest | ImmunoMolecular Therapeutics, LLC | 2018 | |
| Hunter B. Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Saptarsi Haldar | Conflict of Interest | Gladstone Institutes | 2017 | |
| Saptarsi Haldar | Conflict of Interest | Gladstone Institutes | 2017 | |
| Peter Gottlieb | Conflict of Interest | ImmunoMolecular Therapeutics, LLC | 2018 | |
| Zheng Ouyang | Conflict of Interest | Purdue University | 2017 | |
| Michael Chapman | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Ernest Eugene Moore | Conflict of Interest | Thormbo Therapeutics Inc. | 2019 | |
| Ernest Eugene Moore | Conflict of Interest | Thormbo Therapeutics Inc. | 2019 | |
| Hunter B Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Hunter B Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| James C. Moore | Conflict of Interest | Bristol Myers Squibb Pharmaceutical | 2017 | |
| James Degregori | Conflict of Interest | Mitotherapeutix | 2019 | |
| Mark Prausnitz | Conflict of Interest | Clearside Biomedical | 2016 | |
| Michael Chapman | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Ernest Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Ernest Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 | |
| Hunter B. Moore | Conflict of Interest | Thrombo Therapeutics, Inc. | 2019 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.